Cleared Traditional

Tomey Cornea/Anterior Segment OCT (CASIA2)

K250553 · Tomey Corporation · Ophthalmic
Jul 2025
Decision
143d
Days
Class 2
Risk

About This 510(k) Submission

K250553 is an FDA 510(k) clearance for the Tomey Cornea/Anterior Segment OCT (CASIA2), a Tomography, Optical Coherence (Class II — Special Controls, product code OBO), submitted by Tomey Corporation (Nagoya, JP). The FDA issued a Cleared decision on July 18, 2025, 143 days after receiving the submission on February 25, 2025. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.1570.

Submission Details

510(k) Number K250553 FDA.gov
FDA Decision Cleared SESE
Date Received February 25, 2025
Decision Date July 18, 2025
Days to Decision 143 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO — Tomography, Optical Coherence
Device Class Class II — Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.

Similar Devices — OBO Tomography, Optical Coherence

All 64
UNITY DX (UDX)
K252633 · Cylite Pty. , Ltd. · Dec 2025
SPECTRALIS HRA+OCT and variants
K250868 · Heidelberg Engineering GmbH · May 2025
Anterion
K240924 · Heidelberg Engineering GmbH · Dec 2024
SPECTRALIS with Flex Module
K241163 · Heidelberg Engineering GmbH · Oct 2024
3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2); IMAGEnet6 Ophthalmic Data System
K241081 · Topcon Corporation · Jul 2024
SPECTRALIS HRA+OCT and variants
K240221 · Heidelberg Engineering GmbH · Jul 2024